Current and potential indications for Ca2+ antagonists.
Scriabine
A
A
D001927:Brain Diseases / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy
D002121:Calcium Channel Blockers